#BEGIN_DRUGCARD DB01914

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
815-92-9

# ChEBI_ID:
37625

# Chemical_Formula:
C6H12O6

# Chemical_IUPAC_Name:
(2R,3R,4S,5R)-2,3,4,5,6-pentahydroxyhexanal

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
D-Glucose in Linear Form

# HET_ID:
GLO

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5-,6-/m0/s1

# InChI_Key:
InChIKey=GZCGUPFRVQAUEE-FSIIMWSLSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1914

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
180.1559

# Molecular_Weight_Mono:
180.063388116

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1XYM

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.4

# Predicted_LogS:
0.16

# Predicted_Water_Solubility:
2.61e+02 g/l

# Primary_Accession_No:
DB01914

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
167792

# PubChem_Substance_ID:
46507147

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01609

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:37 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Periplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
V00303

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
malE

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
1420181	Sharff AJ, Rodseth LE, Spurlino JC, Quiocho FA: Crystallographic evidence of a large ligand-induced hinge-twist motion between the two domains of the maltodextrin binding protein involved in active transport and chemotaxis. Biochemistry. 1992 Nov 10;31(44):10657-63.
2002054	Spurlino JC, Lu GY, Quiocho FA: The 2.3-A resolution structure of the maltose- or maltodextrin-binding protein, a primary receptor of bacterial active transport and chemotaxis. J Biol Chem. 1991 Mar 15;266(8):5202-19.
6088507	Duplay P, Bedouelle H, Fowler A, Zabin I, Saurin W, Hofnung M: Sequences of the malE gene and of its product, the maltose-binding protein of Escherichia coli K12. J Biol Chem. 1984 Aug 25;259(16):10606-13.
6088520	Froshauer S, Beckwith J: The nucleotide sequence of the gene for malF protein, an inner membrane component of the maltose transport system of Escherichia coli. Repeated DNA sequences are found in the malE-malF intercistronic region. J Biol Chem. 1984 Sep 10;259(17):10896-903.
6185687	Bedouelle H, Schmeissner U, Hofnung M, Rosenberg M: Promoters of the malEFG and malK-lamB operons in Escherichia coli K12. J Mol Biol. 1982 Nov 15;161(4):519-31.
6283312	Bedouelle H, Hofnung M: A DNA sequence containing the control regions of the malEFG and malK-lamB operons in Escherichia coli K12. Mol Gen Genet. 1982;185(1):82-7.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9309217	Quiocho FA, Spurlino JC, Rodseth LE: Extensive features of tight oligosaccharide binding revealed in high-resolution structures of the maltodextrin transport/chemosensory receptor. Structure. 1997 Aug 15;5(8):997-1015.
9600841	Wilkins MR, Gasteiger E, Tonella L, Ou K, Tyler M, Sanchez JC, Gooley AA, Walsh BJ, Bairoch A, Appel RD, Williams KL, Hochstrasser DF: Protein identification with N and C-terminal sequence tags in proteome projects. J Mol Biol. 1998 May 8;278(3):599-608.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3668

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
43388

# Drug_Target_1_Name:
Maltose-binding periplasmic protein precursor

# Drug_Target_1_Number_of_Residues:
396

# Drug_Target_1_PDB_ID:
1LLS

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01547	SBP_bac_1

# Drug_Target_1_Protein_Sequence:
>Maltose-binding periplasmic protein precursor
MKIKTGARILALSALTTMMFSASALAKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIK
VTVEHPDKLEEKFPQVAATGDGPDIIFWAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTW
DAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPALDKELKAKGKSALMFNLQEP
YFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKNKHMNADTDYSIAE
AAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGINAASPNKE
LAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELAKDPRIAATMENAQKGEIMPNIP
QMSAFWYAVRTAVINAASGRQTVDEALKDAQTRITK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-26

# Drug_Target_1_Specific_Function:
Involved in the high-affinity maltose membrane transport system malEFGK. Initial receptor for the active transport of and chemotaxis toward maltooligosaccharides

# Drug_Target_1_SwissProt_ID:
P0AEX9

# Drug_Target_1_SwissProt_Name:
MALE_ECOLI

# Drug_Target_1_Synonyms:
MMBP
Maltodextrin-binding protein

# Drug_Target_1_Theoretical_pI:
5.37

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
xylA

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_2_General_References:
2510821	Farber GK, Glasfeld A, Tiraby G, Ringe D, Petsko GA: Crystallographic studies of the mechanism of xylose isomerase. Biochemistry. 1989 Sep 5;28(18):7289-97.
3508293	Farber GK, Petsko GA, Ringe D: The 3.0 A crystal structure of xylose isomerase from Streptomyces olivochromogenes. Protein Eng. 1987 Dec;1(6):459-66.
8180169	Lavie A, Allen KN, Petsko GA, Ringe D: X-ray crystallographic structures of D-xylose isomerase-substrate complexes position the substrate and provide evidence for metal movement during catalysis. Biochemistry. 1994 May 10;33(18):5469-80.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2431

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
42924

# Drug_Target_2_Name:
Xylose isomerase

# Drug_Target_2_Number_of_Residues:
387

# Drug_Target_2_PDB_ID:
2GYI

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01261	AP_endonuc_2

# Drug_Target_2_Protein_Sequence:
>Xylose isomerase
MSYQPTPEDRFTFGLWTVGWQGRDPFGDATRPALDPVETVQRLAELGAHGVTFHDDDLIP
FGSSDTERESHIKRFRQALDATGMTVPMATTNLFTHPVFKDGGFTANDRDVRRYALRKTI
RNIDLAVELGAKTYVAWGGREGAESGAAKDVRVALDRMKEAFDLLGEYVTSQGYDTRFAI
EPKPNEPRGDILLPTVGHALAFIERLERPELYGVNPEVGHEQMAGLNFPHGIAQALWAGK
LFHIDLNGQSGIKYDQDLRFGAGDLRAAFWLVDLLESAGYEGPRHFDFKPPRTEDIDGVW
ASAAGCMRNYLILKERAAAFRADPEVQEALRASRLDELAQPTAADGVQELLADRTAFEDF
DVDAAAARGMAFERLDQLAMDHLLGAR

# Drug_Target_2_Reaction:
D-xylose = D-xylulose

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Involved in D-xylose catabolism

# Drug_Target_2_SwissProt_ID:
P15587

# Drug_Target_2_SwissProt_Name:
XYLA_STROL

# Drug_Target_2_Synonyms:
EC 5.3.1.5

# Drug_Target_2_Theoretical_pI:
4.76

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasmic

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
U30321

# Drug_Target_3_GenBank_ID_Protein:
927292

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
celCCF

# Drug_Target_3_Gene_Sequence:
>2169 bp
ATGAGTAAGAATTTTAAAAGAGTAGGAGCAGTTGCAGTTGCTGCTGCAATGTCATTATCT
ATAATGGCAACAACCAGCATAAATGCAGCTTCAAGTCCTGCAAACAAGGTGTACCAGGAT
CGTTTTGAATCCATGTACAGCAAGATTAAGGATCCTGCAAACGGATACTTCAGTGAACAG
GGAATTCCTTACCACTCAATTGAAACACTGATGGTCGAAGCTCCTGACTACGGACATGTT
ACAACAAGTGAAGCTATGTCCTATTATATGTGGTTGGAAGCAATGCACGGAAGATTTTCA
GGAGATTTTACAGGTTTTGATAAGTCTTGGTCTGTTACCGAACAGTATTTGATCCCAACA
GAAAAGGATCAGCCCAATACAAGTATGAGCAGATATGATGCTAACAAACCGGCTACATAC
GCTCCGGAATTTCAGGACCCAAGCAAGTATCCTTCTCCGTTGGATACTAGTCAACCTGTT
GGTAGAGATCCAATCAACTCACAATTGACTTCAGCATACGGAACAAGCATGCTGTATGGA
ATGCACTGGATACTTGACGTTGATAACTGGTATGGATTTGGAGCAAGAGCTGATGGAACC
TCCAAGCCATCATATATCAATACTTTCCAAAGAGGTGAGCAGGAGTCAACTTGGGAAACC
ATACCTCAACCATGTTGGGATGAACATAAATTTGGTGGACAGTACGGATTCCTGGATCTC
TTTACAAAGGATACAGGTACTCCGGCAAAGCAATTCAAATATACAAATGCTCCAGATGCT
GATGCTCGTGCAGTTCAAGCAACTTACTGGGCTGATCAGTGGGCAAAAGAACAAGGTAAG
AGCGTAAGTACTAGCGTAGGTAAGGCAACAAAGATGGGTGATTACCTTAGATATTCATTC
TTTGATAAGTATTTCAGAAAGATCGGACAACCTTCTCAGGCTGGTACCGGATATGATGCA
GCACATTATCTGCTTTCATGGTACTATGCATGGGGTGGTGGAATTGACTCTACCTGGTCT
TGGATAATCGGTAGCAGTCATAATCATTTCGGTTACCAGAACCCATTTGCAGCTTGGGTA
CTTTCAACAGATGCAAACTTCAAGCCTAAGTCATCAAATGGTGCATCAGACTGGGCAAAG
AGTTTGGACAGACAGCTTGAATTCTATCAGTGGTTGCAGTCAGCAGAAGGTGCTATTGCC
GGTGGAGCTACAAACTCATGGAACGGACGTTATGAAGCAGTTCCTTCAGGTACATCAACA
TTCTATGGAATGGGTTATGTAGAAAACCCTGTATATGCTGACCCAGGTAGTAACACTTGG
TTTGGTATGCAGGTATGGTCAATGCAGCGTGTAGCTGAATTGTACTATAAGACTGGCGAT
GCCAGAGCTAAGAAACTCTTAGACAAATGGGCAAAATGGATTAATGGCGAAATCAAGTTC
AATGCTGACGGAACATTCCAGATTCCTAGCACAATTGATTGGGAAGGACAGCCGGATACT
TGGAATCCAACACAGGGATACACCGGAAATGCAAACTTGCATGTTAAAGTTGTTAACTAT
GGTACTGACCTAGGTTGTGCTTCTTCACTTGCAAACACATTGACTTACTATGCTGCTAAA
TCAGGAGATGAAACTTCAAGGCAGAATGCACAGAAATTACTTGACGCTATGTGGAATAAC
TATAGCGATTCAAAGGGTATATCAACTGTTGAACAGCGTGGTGATTACCATAGATTCCTT
GATCAGGAAGTTTTTGTACCAGCTGGTTGGACTGGAAAAATGCCTAACGGCGACGTAATC
AAATCTGGTGTCAAGTTCATAGACATTCGTTCCAAGTACAAGCAGGATCCTGAATGGCAG
ACAATGGTTGCTGCATTACAGGCAGGACAGGTTCCAACTCAGAGATTACACCGTTTCTGG
GCTCAGAGTGAATTTGCAGTTGCAAATGGAGTTTATGCAATACTCTTCCCAGATCAAGGT
CCAGAAAAATTATTGGGTGATGTAAACGGTGACGAAACTGTAGACGCTATTGACCTTGCT
ATACTTAAAAAATATCTTTTAAACAGCAGTACTACAATAAATACTGCAAATGCAGATATG
AATAGTGATAATGCTATTGACGCTATTGACTATGCTCTTTTAAAGAAAGCACTTCTTTCT
ATCCAATAG

# Drug_Target_3_General_Function:
Involved in endoglucanase activity

# Drug_Target_3_General_References:
1398087	Bagnara-Tardif C, Gaudin C, Belaich A, Hoest P, Citard T, Belaich JP: Sequence analysis of a gene cluster encoding cellulases from Clostridium cellulolyticum. Gene. 1992 Sep 21;119(1):17-28.
8936327	Reverbel-Leroy C, Belaich A, Bernadac A, Gaudin C, Belaich JP, Tardif C: Molecular study and overexpression of the Clostridium cellulolyticum celF cellulase gene in Escherichia coli. Microbiology. 1996 Apr;142 ( Pt 4):1013-23.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2440

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
80545

# Drug_Target_3_Name:
Endoglucanase F

# Drug_Target_3_Number_of_Residues:
722

# Drug_Target_3_PDB_ID:
1FBO

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00404	Dockerin_1
PF02011	Glyco_hydro_48

# Drug_Target_3_Protein_Sequence:
>Endoglucanase F precursor
MSKNFKRVGAVAVAAAMSLSIMATTSINAASSPANKVYQDRFESMYSKIKDPANGYFSEQ
GIPYHSIETLMVEAPDYGHVTTSEAMSYYMWLEAMHGRFSGDFTGFDKSWSVTEQYLIPT
EKDQPNTSMSRYDANKPATYAPEFQDPSKYPSPLDTSQPVGRDPINSQLTSAYGTSMLYG
MHWILDVDNWYGFGARADGTSKPSYINTFQRGEQESTWETIPQPCWDEHKFGGQYGFLDL
FTKDTGTPAKQFKYTNAPDADARAVQATYWADQWAKEQGKSVSTSVGKATKMGDYLRYSF
FDKYFRKIGQPSQAGTGYDAAHYLLSWYYAWGGGIDSTWSWIIGSSHNHFGYQNPFAAWV
LSTDANFKPKSSNGASDWAKSLDRQLEFYQWLQSAEGAIAGGATNSWNGRYEAVPSGTST
FYGMGYVENPVYADPGSNTWFGMQVWSMQRVAELYYKTGDARAKKLLDKWAKWINGEIKF
NADGTFQIPSTIDWEGQPDTWNPTQGYTGNANLHVKVVNYGTDLGCASSLANTLTYYAAK
SGDETSRQNAQKLLDAMWNNYSDSKGISTVEQRGDYHRFLDQEVFVPAGWTGKMPNGDVI
KSGVKFIDIRSKYKQDPEWQTMVAALQAGQVPTQRLHRFWAQSEFAVANGVYAILFPDQG
PEKLLGDVNGDETVDAIDLAILKKYLLNSSTTINTANADMNSDNAIDAIDYALLKKALLS
IQ

# Drug_Target_3_Reaction:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans ALL_REAC (other) R02886 R06200(G)

# Drug_Target_3_Signals:
1-29

# Drug_Target_3_Specific_Function:
Probable endoglucanase involved in the degradation of cellulose or related beta-glucans

# Drug_Target_3_SwissProt_ID:
P37698

# Drug_Target_3_SwissProt_Name:
GUNF_CLOCE

# Drug_Target_3_Synonyms:
Cellulase F
EC 3.2.1.4
EGCCF
Endo-1,4-beta-glucanase F
Endoglucanase F precursor

# Drug_Target_3_Theoretical_pI:
5.19

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB01914
